NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
NATCO Pharma Limited
-(NATCOPHARM)
XNSE:NATCOPHARM, XBOM:NATCOPHARM
Natco Pharma Ltd Q3 FY24 Earnings Conference Call Insights
Key highlights from Natco Pharma Ltd (NATCOPHARM) Q3 FY24 Earnings Concall Financial Performance Recorded total revenue of INR795.6 crores in Q3 FY'24,
Natco Pharma Ltd Q1FY24; 31% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Natco Pharma Q4FY23 Earnings Story
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
NATCO Pharma Limited Q3FY23 Earnings
A pharmaceutical firm with a strong focus on research and development, NATCO Pharma Ltd creates, produces, and markets sophisticated pharmaceuticals for specialised
NATCO Pharma Limited (NATCOPHARM) Q3 FY23 Earnings Concall Transcript
NATCO Pharma Limited (NSE:NATCOPHARM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Rajesh Chebiyam -- Executive Vice President of Crop Health Science
NATCO Pharma Limited (NATCOPHARM) Q2 FY22 Earnings Concall Transcript
NATCO Pharma Limited (NSE:NATCOPHARM) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rajeev Nannapaneni -- Director and Chief Executive Officer Rajesh Chebiyam -- Executive
NATCO Pharma Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=bt9cDow2-2c Key highlights from NATCO Pharma Limited (NATCOPHARM) Q3 FY22 Earnings Concall Q&A Highlights: Tarang Agrawal from Old Bridge asked about the